Insights (60)
Filter
-
Preparing your plan for the GLP-1 era
After revolutionizing care for diabetes and weight loss, GLP-1 drugs are being eyed more. Can we afford it?
-
Autoimmune, oncology, diabetes and obesity rule drug spending
Many patients combined with expensive drugs leads to top spending classes.
-
Specialty drugs: Not just set and forget?
For optimizing specialty drug therapy, monitoring patients throughout their care is key to cost-effective use of high-cost drugs.
-
The latest PBM regulations: Summer 2024
Get your guide to the evolving health care regulatory landscape and see what’s coming as lawmakers debate 600+ new bills impacting PBMs.
-
Get immediate savings on specialty drugs
Specialty drug spend is a "top threat" to employer-provided benefits. Discover sustainable savings with your existing Optum Rx plan.
-
Building the PBM of the future
Creating solutions plan sponsors need today to tackle tomorrow’s pharmacy challenges.
-
Connections that count: Redefining the PBM experience
Hear from experts on better ways to simplify the complex health care experience through impactful innovation.
-
Eliminating surprises in pharmacy spend
Old strategies and new drugs don’t mix. Future-proof your plan and get better predictability with new specialty pricing models.
-
What to consider about weight loss drugs
Get the most from these pricey new obesity drugs by choosing the right coverage strategy and helping your members build lifelong habits.
-
Regulations to watch: Spring 2024
Get the latest on legislation impacting PBM operations.
-
The new drugs plan sponsors need to watch for
See which trends to consider when assessing the pharmacy benefit, which new drugs may be flying under the radar and what's coming.
-
Regulatory updates with Optum Rx
Stay up-to-date on what’s happening in pharmacy legislation.
-
Health Equity Vision Into Action Report
Learn how identifying and addressing disparities in health care allows everyone to live their healthiest life.
-
Transforming the pharmacy industry with transparency
Hear how the industry’s most transparent and independent Pharmacy & Therapeutics Committee evaluates drugs for the Optum Rx formulary.
-
Regulatory update: Winter 2023
Get the latest on legislation impacting PBMs.
-
5 trends that defined pharmacy in 2023
See which trends are shaping the present and future of pharmacy care services.
-
Gene therapies: Can we afford the future of medicine?
Learn how to manage financial risk as gene therapies become more commonplace.
-
Experts agree: PBMs add value, lower costs
PBMs don’t cause high drug costs — they’re part of the solution. Our drug prices beat the “low cost” vendors.
-
3 ways to address vaccine fatigue
Learn about researched vaccine messaging themes and important steps you can take to promote critical vaccinations for members.
-
How to manage blockbuster anti-obesity drugs
The pricey weight management drugs work well, but users need coaching and support to maintain the benefits.
-
Alzheimer's treatment: Time for a level-set?
See success rates, risks and costs of the new Alzheimer’s treatments.
-
Regulations to watch: Fall 2023
Learn what's at stake as the PBM legislation advances on Capitol Hill.
-
Redefining the prior authorization process
How we are revamping the prescribing process
-
Addressing pharmacy issues that matter to you
From specialty pharmacy to drug affordability, our experts tackle your biggest pharmacy challenges.